Radcliffe Capital Management, L.P. - MONTEREY BIO ACQUISITION COR ownership

MONTEREY BIO ACQUISITION COR's ticker is and the CUSIP is 61240F116. A total of 34 filers reported holding MONTEREY BIO ACQUISITION COR in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Radcliffe Capital Management, L.P. ownership history of MONTEREY BIO ACQUISITION COR
ValueSharesWeighting
Q3 2023$5,000
-12.7%
200,0000.0%0.00%
Q2 2023$5,730
+0.5%
200,0000.0%0.00%
Q1 2023$5,700
-99.7%
200,0000.0%0.00%
-100.0%
Q4 2022$2,100,000
+3.9%
200,0000.0%0.07%
+34.7%
Q3 2022$2,022,000
+0.9%
200,0000.0%0.05%
+6.5%
Q2 2022$2,004,000
+0.6%
200,0000.0%0.05%
+2.2%
Q1 2022$1,993,000
+0.9%
200,0000.0%0.04%
-13.5%
Q4 2021$1,975,000200,0000.05%
Other shareholders
MONTEREY BIO ACQUISITION COR shareholders Q1 2023
NameSharesValueWeighting ↓
MANGROVE PARTNERS IM, LLC 276,634$3,020,8430.21%
BOOTHBAY FUND MANAGEMENT, LLC 388,437$4,241,7320.09%
ATW SPAC MANAGEMENT LLC 384,993$11,0300.01%
EHP Funds Inc. 938,629$26,8920.01%
MMCAP International Inc. SPC 625,000$16,5630.01%
Arena Investors LP 133,500$3,9120.00%
K2 PRINCIPAL FUND, L.P. 395,000$10,6260.00%
HGC Investment Management Inc. 160,000$50.00%
Terrapin Asset Management, LLC 22,600$6470.00%
CVI Holdings, LLC 42,907$1,1370.00%
View complete list of MONTEREY BIO ACQUISITION COR shareholders